Evidence map›Paper›PMID 42283729›Full record

ArticleTheory in biosciences = Theorie in den Biowissenschaften2026

An investigative network analysis mapping global cancer epidemiology.

Sheena Yi-Hsin Cheng, Yi-Chiung Hsu, Shih-Ping Cheng

Abstract read
PubMed Publisher
In one paragraph

Article in Theory in biosciences = Theorie in den Biowissenschaften, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sheena Yi-Hsin ChengBiochemistry Program, University of Southern California, Los Angeles, CA, USA.
Yi-Chiung HsuDepartment of Biomedical Sciences and Engineering, National Central University, Taoyuan, Taiwan.
Shih-Ping ChengDepartment of Surgery, MacKay Memorial Hospital, 92, Chung-Shan North Road, Section 2, Taipei, 104217, Taiwan. t119@mmu.edu.tw.ORCID http://orcid.org/0000-0002-6301-5096

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer incidence is influenced by a combination of extrinsic and genetic factors. We hypothesized that cancers with similar incidence patterns may suggest shared etiologies. Age-standardized incidence rates for 36 cancer types across 185 countries were obtained from GLOBOCAN 2022. Pairwise Spearman's correlation coefficients were computed, and network clustering analyses were performed using six community detection algorithms: Leiden, Surprise, Walktrap, Girvan-Newman, Infomap, and spectral clustering. A dominant cluster was consistently identified, comprising kidney, pancreatic, colorectal, and thyroid cancers, as well as hematological malignancies. The second cluster comprised lung cancer, mesothelioma, melanoma, and non-melanoma skin cancer, which were grouped with head and neck cancers in some algorithms. Kaposi's sarcoma, nasopharyngeal cancer, and salivary gland cancer were classified individually. The dominant cluster showed significantly greater enrichment of shared mutational signatures (cosine similarity, p = 0.041) and recurrent mutation overlap (Jaccard similarity, p = 0.025) than expected by chance. Additionally, eigenvector centrality positively correlated with global cancer incidence rates. Overall, this unsupervised network analysis of global cancer epidemiology identifies biologically coherent clusters that reflect potentially shared etiological mechanisms and may inform public health intervention strategies.

Indexed as

NeoplasmsAlgorithmsCluster AnalysisGlobal HealthHumansIncidenceMutationCancer incidenceCommunity detectionEpidemiologyGLOBOCANNetwork analysis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.